Key points are not available for this paper at this time.
Using large cohorts of well-characterized subjects from different centers allowed construction of robust reference ranges for a new automated IGF-I assay. The strict adherence to recent consensus criteria for IGF-I assays might facilitate clinical application of the results.
Bidlingmaier et al. (Mon,) studied this question.